CLINICAL TRIAL

Cuba will evaluate the safety and immunogenicity of the vaccine candidate Mambisa and the Abdala vaccine with people who suffered from COVID-19»

Having met the requirements established by the the Center for State Control of Medicines and Medical Equipment (CECMED) of Cuba, Abdala vaccine candidate has been approved for application throughout the island»

Cuban Research Ethics Committee reviews clinical trial to determine the best formulation of Soberana 01 and Soberana 02 in pediatric population»

The vaccine is being developed by the Belgian pharmaceutical company Janssen»

More than 40 clinical trials implemented in the Cuban central province of Sancti Spiritus have benefited the vast majority of patients, ensured specialists involved in the task. In the first provincial workshop on the topic it was announced that all studies (over 40 since 1992) had encouraging results and allowed assessing, experimentally, various drugs, finally valued as effective and safe.»

Some 70 patients in Sancti Spiritus province suffering from different carcinogenic pathologies are included in the various clinical trials developed in the Cuban central territory, as part of the treatment against cancer, disease which consitutes the first cause of death in the region.»